Estimating the Benefit of Preoperative Systemic Therapy to Reduce the Extent of Breast Cancer Surgery: Current Standard and Future Directions-Reference-Cited by-同舟云学术

Estimating the Benefit of Preoperative Systemic Therapy to Reduce the Extent of Breast Cancer Surgery: Current Standard and Future Directions

Published:2023 Issue: Volume: Page:149-174
ISSN:0927-3042
Container-title:Cancer Treatment and Research
language:en
Short-container-title:

Author:

Montagna Giacomo

Publisher

Springer International Publishing

Link

https://link.springer.com/content/pdf/10.1007/978-3-031-33602-7_6

Reference117 articles.

1. King TA, Morrow M (2015) Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy. Nat Rev Clin Oncol 12(6):335–343. https://doi.org/10.1038/nrclinonc.2015.63

2. Burstein HJ, Curigliano G, Loibl S, Dubsky P, Gnant M, Poortmans P, Colleoni M, Denkert C, Piccart-Gebhart M, Regan M, Senn HJ, Winer EP, Thurlimann B, Members of the St Gallen International Consensus Panel on the Primary Therapy of Early Breast C (2019) Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019. Ann Oncol 30(10):1541–1557. https://doi.org/10.1093/annonc/mdz235

3. Dubsky P, Pinker K, Cardoso F, Montagna G, Ritter M, Denkert C, Rubio IT, de Azambuja E, Curigliano G, Gentilini O, Gnant M, Gunthert A, Hauser N, Heil J, Knauer M, Knotek-Roggenbauerc M, Knox S, Kovacs T, Kuerer HM, Loibl S, Mannhart M, Meattini I, Penault-Llorca F, Radosevic-Robin N, Sager P, Spanic T, Steyerova P, Tausch C, Peeters M, Weber WP, Cardoso MJ, Poortmans P (2021) Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox. Lancet Oncol 22(1):e18–e28. https://doi.org/10.1016/S1470-2045(20)30580-5

4. https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. National comprehensive cancer network: NCCN clinical practice guidelines in oncology (Breast Cancer) version 5.2021. Accessed 28 Jun 2021

5. Masuda N, Lee SJ, Ohtani S, Im YH, Lee ES, Yokota I, Kuroi K, Im SA, Park BW, Kim SB, Yanagita Y, Ohno S, Takao S, Aogi K, Iwata H, Jeong J, Kim A, Park KH, Sasano H, Ohashi Y, Toi M (2017) Adjuvant capecitabine for breast cancer after preoperative chemotherapy. N Engl J Med 376(22):2147–2159. https://doi.org/10.1056/NEJMoa1612645